2
votes

Priligy: a New Drug for Premature Ejaculation

Mar 15, 2010
A novel drug to treat premature ejaculation was approved and is now available in New Zealand pharmacies.

PRILIGY, a drug containing dapoxetine hydrochloride is recommended for men with premature ejaculation aged 18 to 64. It works by boosting the levels of serotonin hormone that delays and helps to have better control over ejaculation. This will reduce the sexual performance anxiety and result in higher sexual satisfaction. Men can feel the improvements right after the first use of the PRILIGY or after a few times, manufacturers claim.

The medicine comes in a form of a tablet that should be taken orally 1 to 3 hours before sexual intercourse and no more than once in 24-hours. The pill is available in 30 mg and 60 mg. Men should avoid alcohol if they want to use PRILIGY because they may have such side effects as fainting or other alcohol-related problems. It is also advised to avoid recreational drugs, including ecstasy, LSD, narcotics and benzodiazepines as it may result in serious health problems.

In some cases men can experience mild side effects of the drug, which may include dizziness, tiredness or headache.

Premature ejaculation is a wide-spread condition affecting up to 25 percent of men at least once in their life. It is determined as an inability to control when ejaculation occurs, which usually happens shortly before, during or after penetration and before a man wants to. The problem of premature ejaculation often causes psychological distress and dissatisfaction for a man and his partner.

The treatment of premature ejaculation includes counseling and other psychological treatments as well as the use of various products to delay ejaculation. These may include the use of local anesthetic gels and long love condoms that contain a lubricant with a local anaesthetic to prolong the intercourse.

Related:


Notice: All Comments are moderated, offensive or off-topic comments will be deleted.
You can also stay up to date using your favorite aggregator by subscribing to the RSS

Name: 
Text: 
Enter the code shown »